5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.85%
Gross profit growth similar to METSB.HE's 0.85%. Walter Schloss would assume both firms track common industry trends.
5.50%
EBIT growth similar to METSB.HE's 5.50%. Walter Schloss might infer both firms share similar operational efficiencies.
5.50%
Operating income growth similar to METSB.HE's 5.50%. Walter Schloss would assume both share comparable operational structures.
-2.93%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-14.29%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-14.29%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
13.25%
Share count expansion well above METSB.HE's 13.25%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.25%
Diluted share count expanding well above METSB.HE's 13.25%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
0.45%
Similar OCF growth to METSB.HE's 0.45%. Walter Schloss would assume comparable operations or industry factors.
5.36%
FCF growth similar to METSB.HE's 5.36%. Walter Schloss would attribute it to parallel capital spending and operational models.
-38.04%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-42.49%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-36.19%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
4.86%
10Y OCF/share CAGR in line with METSB.HE's 4.86%. Walter Schloss would see both as similarly efficient over the decade.
-217.21%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-355.17%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
120.93%
Similar net income/share CAGR to METSB.HE's 120.93%. Walter Schloss would see parallel tailwinds or expansions for both firms.
135.29%
5Y net income/share CAGR similar to METSB.HE's 135.29%. Walter Schloss might see both on parallel mid-term trajectories.
-0.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-6.29%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-6.77%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
132.59%
3Y dividend/share CAGR similar to METSB.HE's 132.59%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-7.18%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
6.31%
Inventory growth well above METSB.HE's 6.31%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.84%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-10.52%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
1.15%
Debt growth far above METSB.HE's 1.15%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-4.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.